Fukuda Denshi (6960) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
9 Sep, 2025Executive summary
Net sales rose 4.0% year-over-year to ¥30,341 million for the first quarter ending June 30, 2024.
Operating profit declined 11.5% year-over-year to ¥4,515 million, and ordinary profit fell 11.1% to ¥4,647 million.
Profit attributable to owners of parent decreased 13.3% year-over-year to ¥3,031 million.
Comprehensive income dropped 29.6% year-over-year to ¥3,025 million.
Financial highlights
Gross profit increased to ¥14,236 million from ¥12,811 million year-over-year.
Earnings per share for the quarter were ¥105.15, down from ¥115.54 a year earlier.
Total assets decreased to ¥206,095 million from ¥209,064 million at the previous fiscal year-end.
Net assets slightly decreased to ¥168,985 million.
Outlook and guidance
Full-year forecast remains unchanged: net sales of ¥135,000 million (+3.8%), operating profit of ¥23,000 million (+13.2%), and profit attributable to owners of parent of ¥16,500 million (+11.7%).
No interim forecast is provided due to business seasonality.
Latest events from Fukuda Denshi
- Slight YoY profit decline offset by strong comprehensive income and stable full-year outlook.6960
Q3 20265 Feb 2026 - Net sales up 0.8% and operating profit steady, with segment shifts and stable full-year outlook.6960
Q2 202612 Nov 2025 - First-half profits fell on lower sales, but full-year guidance and dividend plans remain unchanged.6960
Q2 20259 Sep 2025 - Profits declined despite stable sales, with mixed segment performance and steady full-year outlook.6960
Q3 20259 Sep 2025 - Slight declines in sales and profit, with FY2026 guidance indicating further contraction.6960
Q4 20259 Sep 2025 - Profits declined despite stable sales; medical treatment and consumables segments showed growth.6960
Q1 20269 Sep 2025